BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 8610948)

  • 1. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
    Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR
    Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group.
    Toma E; Thorne A; Singer J; Raboud J; Lemieux C; Trottier S; Bergeron MG; Tsoukas C; Falutz J; Lalonde R; Gaudreau C; Therrien R
    Clin Infect Dis; 1998 Sep; 27(3):524-30. PubMed ID: 9770152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial.
    Toma E; Fournier S; Dumont M; Bolduc P; Deschamps H
    Clin Infect Dis; 1993 Aug; 17(2):178-84. PubMed ID: 8399863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of clindamycin/primaquine versus trimethoprim/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia.
    Ruf B; Rohde I; Pohle HD
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):207-10. PubMed ID: 2060533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.
    Barber BA; Pegram PS; High KP
    Clin Infect Dis; 1996 Oct; 23(4):718-22. PubMed ID: 8909833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
    Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
    N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study.
    Helweg-Larsen J; Benfield T; Atzori C; Miller RF
    J Antimicrob Chemother; 2009 Dec; 64(6):1282-90. PubMed ID: 19858161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Pneumocystis carinii pneumonia in adults with AIDS.
    Deresinski SC
    Semin Respir Infect; 1997 Jun; 12(2):79-97. PubMed ID: 9195673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia.
    Smego RA; Nagar S; Maloba B; Popara M
    Arch Intern Med; 2001 Jun; 161(12):1529-33. PubMed ID: 11427101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
    Korraa H; Saadeh C
    South Med J; 1996 Mar; 89(3):272-7. PubMed ID: 8604455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
    Antinori A; Murri R; Ammassari A
    AIDS; 1996 Aug; 10(9):1046-7. PubMed ID: 8853743
    [No Abstract]   [Full Text] [Related]  

  • 12. Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.
    Black JR; Feinberg J; Murphy RL; Fass RJ; Finkelstein D; Akil B; Safrin S; Carey JT; Stansell J; Plouffe JF
    Clin Infect Dis; 1994 Jun; 18(6):905-13. PubMed ID: 8086551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
    N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
    Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
    Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy and prevention of pneumocystis carinii pneumonia].
    Goebel FD; Bogner JR
    Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia.
    Blum RN; Miller LA; Gaggini LC; Cohn DL
    J Acquir Immune Defic Syndr (1988); 1992; 5(4):341-7. PubMed ID: 1548570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clindamycin and primaquine as primary treatment for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS.
    Black JR; Feinberg J; Murphy RL; Fass RJ; Carey J; Sattler FR
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):204-7. PubMed ID: 2060532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome.
    Montgomery AB; Feigal DW; Sattler F; Mason GR; Catanzaro A; Edison R; Markowitz N; Johnson E; Ogawa S; Rovzar M
    Am J Respir Crit Care Med; 1995 Apr; 151(4):1068-74. PubMed ID: 7697233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC; Griffith L; Guyatt GH; Opravil M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clindamycin-primaquine versus pentamidine for the second-line treatment of pneumocystis pneumonia.
    Kim T; Kim SH; Park KH; Cho OH; Sung H; Kim MN; Choi SH; Jeong JY; Woo JH; Kim YS; Lee SO
    J Infect Chemother; 2009 Oct; 15(5):343-6. PubMed ID: 19856077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.